ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Facilities Manager at Superluminal Medicines, Inc. - ApplyBlast

Facilities Manager

Superluminal Medicines, Inc.

2 months ago

Boston, Massachusetts, United States

Onsite

Full Time

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Facilities Manager will oversee daily operations, maintenance, safety, and continuous improvement of Superluminal Medicines' 27,000‑square‑foot Boston facility, ensuring building systems and lab support services run efficiently and reliably. The role serves as the primary liaison among internal teams, building management, and vendors, managing projects, regulatory compliance, and on‑call emergency support.

Responsibilities

Oversee daily operations and maintenance of lab and office facilities
Lead facility improvement projects and manage contractors and budgets
Coordinate lab utilities and vendor services to ensure uninterrupted research

Skills

Qualifications

Bachelor's degree in Facilities Management, Engineering, Biotechnology, or related technical field

About Superluminal Medicines, Inc.

superluminalrx.com

Headquarters

Boston, Massachusetts, United States

Company Size

1-10 employees

View Profile

Superluminal Medicines is a biotechnology company accelerating drug discovery and development to deliver next‑generation small‑molecule therapeutics. Their Hyperloop™ platform combines structure‑based drug design with AI‑driven computational methods and experimental validation to identify and optimize candidates. Initially focused on GPCR targets, their pipeline emphasizes patient‑centric precision to develop treatments for cardiometabolic diseases.

Recent company news

Business Wire

Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship

Jun 23, 2025